Shinichi Koizumi

Director/Board Member at TSUBOTA LABORATORY INCORPORATED

68 year

Health Technology

Consumer Services

Commercial Services

Profile

Shinichi Koizumi is currently the Director, Vice President & CSO at AskAt, Inc. He is also an Independent Outside Director at Tsubota Laboratory, Inc. In the past, he served as the Executive Vice President at RaQualia Pharma, Inc. Dr. Koizumi holds a doctorate degree from Tokyo Institute of Technology, which he obtained in 1986.

Shinichi Koizumi active positions

Companies	Position	Start
TSUBOTA LABORATORY INCORPORATED	Director/Board Member	31/05/2020
AskAt, Inc. AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015.	Chief Tech/Sci/R&D Officer	31/12/2012

All active positions of Shinichi Koizumi

Former positions of Shinichi Koizumi

Companies	Position	End
RAQUALIA PHARMA INC.	Chief Tech/Sci/R&D Officer	28/11/2012

See the detail of Shinichi Koizumi's experience

Training of Shinichi Koizumi

Tokyo Institute of Technology

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shinichi Koizumi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
RAQUALIA PHARMA INC.	Health Technology
TSUBOTA LABORATORY INCORPORATED	Commercial Services

Private companies	1
AskAt, Inc. AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015.	Health Technology